Clinical Research Directory
Browse clinical research sites, groups, and studies.
Bone-sparing Chemoradiotherapy for Anal Cancer - DACG-II
Sponsor: Karen-Lise Garm Spindler
Summary
This study proposal includes a prospective clinical trial of bone sparing treatment planning in anal cancer patients. the trial aim to lower the risk of bone damage, while adhering with the constrains to the bowel, bladder and other conventional Organs At Risk, and finally to describe the fraction of pelvic insufficiency fractures in patients treated with optimized radiotherapy.
Official title: Bone-sparing Chemoradiotherapy for Anal Cancer - A Prospective Phase II Trial Danish Anal Cancer Group Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2021-08-23
Completion Date
2026-03-01
Last Updated
2024-08-15
Healthy Volunteers
No
Conditions
Interventions
Bone sparring radiotherapy
Observation of late side effects from the pelvic bones after bone-sparring radiotherapy for anal cancer
Locations (1)
Aarhus University Hospital
Aarhus, Denmark